ArticleScientific reports2026
Evaluation of a sensitive real-time PCR assay for Group B Streptococcus detection in vaginal-rectal swab.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Group B Streptococcus (GBS) is associated with invasive infections in newborns. The obstetric field requires a rapid method for obtaining GBS screening results. Our objective was to determine whether a sensitive real-time PCR assay demonstrates acceptable diagnostic performance. This study involved 301 pregnant women. Vaginal and rectal swabs were collected between 35 and 37 weeks of gestation. We report the diagnostic performance of the sensitive real-time PCR assay compared to composite reference method, along with 95% confidence intervals (CI). Positive results were detected in 35 cases (11.6%), 27 cases (8.9%), and 21 cases (6.9%), using real-time PCR, real-time PCR after enrichment, and microbial culture methods, respectively. Microbial culture and sequencing were applied as composite reference method, the sensitivity of real-time PCR was 96.15%, specificity was 96.36%, and diagnostic accuracy was 96.34%. Compared with the composite reference method, the sensitivity and specificity of the real-time PCR detection method after enrichment was 96.15% and 99.27%, with a diagnostic accuracy of 99.0%. Microbial culture demonstrated a sensitivity of 80.77%, specificity of 100%, and diagnostic accuracy of 98.33%. This study demonstrates that the sensitive real-time PCR assay represents an acceptable rapid GBS screening method, offering clinicians a new option for early screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.